ELI LILLY & Co
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Other Cardiometabolic Health medicines by Year
Other Cardiometabolic Health medicines — U.S. revenue ($M) ($M)
Eli Lilly Other Cardiometabolic Health medicines: $2,233M in FY2025, down 16.7% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-12) ↗
Reported in Form 10-Q / 10-K Note 2 Disaggregated Revenue.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Cardiometabolic Health medicines — U.S. revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,233 | -16.7% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 2,682 | -2.0% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 2,738 | +1,632.9% | Form 10-K (filed 2026-02-12) ↗ |
| FY2022 | Dec 31, 2022 | 158 | – | Form 10-K (filed 2025-02-19) ↗ |
Breakdown
What makes up other Cardiometabolic Health medicines
Cite this data
StockData. (2026). Eli Lilly Other Cardiometabolic Health medicines ($M), annual FY2022–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-other-cm-us
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.